Mesophotonics Includes ACD/Labs UV-IR Software Platform for use with its Raman Instruments
News Jun 06, 2006
Advanced Chemistry Development, Inc., (ACD/Labs) and Mesophotonics, Ltd. have announced that Mesophotonics SE1000 Raman system will now include ACD/Labs UV-IR software for processing, interpreting, searching, and managing Raman spectra.
Mesophotonics’ Klarite® substrates for surface enhanced Raman spectroscopy (SERS) are designed to offer unparalleled levels of reproducibility and signal consistency enabling rapid detection to parts per billion level.
The SE1000 combines Klarite with a compact Raman spectrometer and ACD/Labs UV-IR software, offering an all-in-one toolkit for SERS analysis.
ACD/UV-IR Processor and ACD/UV-IR Manager are part of ACD/SpecManager, the overall spectroscopic processing and data management software that unifies analytical data information of all types into a single interface.
Composed of three tightly integrated modules, UV-IR Manager provides the ability to manipulate and manage optical spectra in a continuous range from 1 cm-1 to 100 000 cm-1, while taking advantage of advanced chemical drawing and reporting features.
UV-IR Processor provides an interface for peak fitting, baseline correction, and analysis and interpretation of Raman spectra, along with structure integration and reporting tools.
Michael Boruta, Optical Spectroscopy Product Manager at ACD/Labs, states, "We are pleased to be working with Mesophotonics to make our software available to their customers."
"We believe SERS to be a growing market with a strong need for software tools to assist in the analysis, interpretation, management, and linking of structures and spectrum-structure correlations with Raman spectra."
Steve Allen, VP Analytical Business of Mesophotonics, Inc., states, "We are delighted to include ACD/Labs UV-IR software with our instruments."
"For our customers this means access to their excellent processing and interpretation tools."
"The ease with which you can annotate and interpret spectra, add structures, and create reports makes their software a valuable addition to our instruments."
The ideal drug is one that only affects the exact cells and neurons it is designed to treat, without unwanted side effects. This concept is especially important when treating the delicate and complex human brain. Now, scientists have revealed a mechanism that could lead to this kind of long-sought specificity for treatments of strokes and seizures.READ MORE